Cytotoxicity of CD56bright NK Cells Towards Autologous Activated CD4+ T Cells Is Mediated Through NKG2D, LFA-1 and TRAIL and Dampened via CD94/NKG2A

PLoS ONE - United States
doi 10.1371/journal.pone.0031959
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Tumor Killing by CD4+ T Cells Is Mediated via Induction of Inducible Nitric Oxide Synthase-Dependent Macrophage Cytotoxicity

Frontiers in Immunology
AllergyImmunology
2018English

Porcine UL16-Binding Protein 1 Expressed on the Surface of Endothelial Cells Triggers Human NK Cytotoxicity Through NKG2D

Journal of Immunology
AllergyImmunology
2006English

A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+T Cells

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2016English

IFN- Production by Plasmacytoid Dendritic Cells Stimulated With RNA-Containing Immune Complexes Is Promoted by NK Cells via MIP-1 and LFA-1

Journal of Immunology
AllergyImmunology
2011English

Increase of NKG2D Ligands and Sensitivity to NK Cell-Mediated Cytotoxicity of Tumor Cells by Heat Shock and Ionizing Radiation

Experimental & Molecular Medicine
2006English

LFA-1 Regulates CD8+T Cell Activation via T Cell Receptor-Mediated and LFA-1-mediated Erk1/2 Signal Pathways

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2009English

CD4+NKG2D+ T Cells Exhibit Enhanced Migratory and Encephalitogenic Properties in Neuroinflammation

PLoS ONE
Multidisciplinary
2013English

γδT Cells Suppress Liver Fibrosis via Strong Cytolysis and Enhanced NK Cell-Mediated Cytotoxicity Against Hepatic Stellate Cells

Frontiers in Immunology
AllergyImmunology
2019English

Effect of Apatinib on Serum CD4+CD25+ T Cells, NK Cells, and T Cells Subgroup in Malignant Tumor

Technology in Cancer Research and Treatment
MedicineCancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy